Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 1, 2011, Pages 34-37

  Smith, Jessica R ^a,b   Marqusee, Ellen ^b   Webb, Susan ^a   Nose, Vania ^c   Fishman, Steven J ^a   Shamberger, Robert C ^a   Frates, Mary C ^b   Huang, Stephen A ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADOLESCENT; ADULT; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FOLLICULAR CARCINOMA; GOITER; HAMARTOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MEDICAL RECORD; MULTIPLE ENDOCRINE NEOPLASIA; MUTATIONAL ANALYSIS; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE HAMARTOMA TUMOR SYNDROME; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCREENING TEST; SUBTOTAL THYROIDECTOMY; THYROID CANCER; THYROID NODULE; THYROIDECTOMY; TUMOR VOLUME; ULTRASOUND;

EID: 78650866464     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1315     Document Type: Conference Paper

References (10)

1. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R 1997 Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64-67
2. Pilarski R, Eng C 2004 Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 41:323-326
3. Daly MB, Axilbund JE, Buys S, Crawford B, Farrell CD, Friedman S, Garber JE, Goorha S, Gruber SB, Hampel H, Kaklamani V, Kohlmann W, Kurian A, Litton J, Marcom PK, Nussbaum R, Offit K, Pal T, Pasche B, Pilarski R, Reiser G, Shannon KM, Smith JR, Swisher E, Weitzel JN 2010 Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw 8:562-594
4. Zambrano E, Holm I, Glickman J, Huang S, Perez-Atayde A, Kozakewich HP, Shamberger RC, Nosé V 2004 Abnormal distribution and hyperplasia of thyroid C-cells in PTEN-associated tumor syndromes. Endocr Pathol 15:55-64
5. Tan WH, Baris HN, Burrows PE, Robson CD, Alomari AI, Mulliken JB, Fishman SJ, Irons MB 2007 The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. J Med Genet 44:594-602
6. den Dunnen JT, Antonarakis SE 2000 Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7-12
7. Lachlan KL, Lucassen AM, Bunyan D, Temple IK 2007 Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet 44:579-585 (Pubitemid 47441766)
8. Vassilopoulou-Sellin R, Goepfert H, Raney B, Schultz PN 1998 Differentiated thyroid cancer in children and adolescents: clinical outcome and mortality after long-term follow-up. Head Neck 20:549-555 (Pubitemid 28361461)
9. Marqusee E, Benson CB, Frates MC, Doubilet PM, Larsen PR, Cibas ES, Mandel SJ 2000 Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 133:696-700
10. Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214